Business Standard

Larus Labs enters agreement with Global Fund for supply of AIDS drugs

Through this agreement Laurus Labs will have the volume commitments from the Global Fund for the treatment of HIV/AIDS

Photo: Shutterstock
Premium

<b> Photo: Shutterstock <b>

BS Reporter Hyderabad
Hyderabad-based pharma company Laurus Labs Limited announced on Tuesday that it has entered into a strategic partnership agreement with Global Fund for a period of 3.5 years. Through this agreement Laurus Labs will have the volume commitments from the Global Fund for the treatment of HIV/AIDS.

The company has already received and executed the order from the global charity agency which would cater to the supples of the high burden diseases countries in Sub Saharan African(SSA) region. This is also the maiden order for  Tenofovir/Lamivudine/Dolutegravir 300/300.50 mg(TLD) after the company has received a tentative approval from the US Food and Drug

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Mar 26 2019 | 3:37 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com